NewsWhore
04-23-2012, 07:10 AM
on, is also looking at a range of other biotech assets - but its research head would not be drawn on interest in Amylin Pharmaceuticals. Amylin has started reaching out to potential buyers after ...
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/205161583/)
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/205161583/)